Clinical trial
Lipidomics for Identification of New Biomarkers for Fabry Disease
NCT05046379 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipidomics for Identification of New Biomarkers for Fabry Disease
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 14, 2021
- Completion date
- April 28, 2024
- Enrollment
- 108 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.